BDBM37591 3-methyl-2-oxidanylidene-N-[1-(phenylmethyl)piperidin-4-yl]-1,3-benzoxazole-6-sulfonamide::3-methyl-2-oxo-N-[1-(phenylmethyl)-4-piperidinyl]-1,3-benzoxazole-6-sulfonamide::MLS000117429::N-(1-benzyl-4-piperidyl)-2-keto-3-methyl-1,3-benzoxazole-6-sulfonamide::N-(1-benzylpiperidin-4-yl)-3-methyl-2-oxo-1,3-benzoxazole-6-sulfonamide::SMR000094377::cid_2036437

SMILES Cn1c2ccc(cc2oc1=O)S(=O)(=O)NC1CCN(Cc2ccccc2)CC1

InChI Key InChIKey=YJGLJCKFGWIIPL-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 37591   

TargetHuntingtin(Human)
Columbia University Molecular Screening Center

Curated by PubChem BioAssay
LigandPNGBDBM37591(3-methyl-2-oxo-N-[1-(phenylmethyl)-4-piperidinyl]-...)
Affinity DataIC50: 8.00E+3nMAssay Description:The mutation underlying Huntington's disease is an expansion of a polyglutamine tract in the N-terminus of the protein huntingtin (htt). Under no...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/29/2011
Entry Details
PCBioAssay